![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![Will Mylan's big Copaxone price break force Teva's hand? Clients are pushing already | Fierce Pharma Will Mylan's big Copaxone price break force Teva's hand? Clients are pushing already | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1531750120/Copaxone.jpg/Copaxone.jpg?VersionId=hpmMjG7qbSl2HWPXOwxDsXVj6TQPn_Fe)
Will Mylan's big Copaxone price break force Teva's hand? Clients are pushing already | Fierce Pharma
![Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Stock Photo - Image of medical, gastroesophageal: 187163353 Omeprazole Generic Drug Box by Teva Closeup Against White Editorial Stock Photo - Image of medical, gastroesophageal: 187163353](https://thumbs.dreamstime.com/z/kyiv-ukraine-may-gastroenterology-generic-drug-omeprazole-teva-box-blisters-closeup-white-pharmaceuticals-american-187163353.jpg)